The interaction of methamphetamine with human immunodeficiency virus (HIV),
the aetiologic agent of Acquired Immune Deficiency Syndrome (AIDS), has no
t been thoroughly investigated. However, increasingly, a larger proportion
of HIV infected individuals acquire the virus through methamphetamine use o
r are exposed to this drug during their disease course. In certain populati
ons, there is a convergence of methamphetamine use and HIV-1 infection; yet
our understanding of the potential effects that simultaneous exposure to t
hese two agents have on disease progression is extremely limited. Studying
the interactions between methamphetamine and lentivirus in people is diffic
ult. To thoroughly understand methamphetamine's effects on lentivirus disea
se progression, an animal model that is both clinically relevant and easily
manipulated is essential. In this report, we identified potential problems
with methamphetamine abuse in individuals with a concurrent HIV-1 infectio
n, described the Feline Immunodeficiency Virus (FIV)/cat model for HIV-1, a
nd reported our early findings using this modelling system to study the int
eraction of methamphetamine and lentivirus infections.